Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia

Clinical and Experimental Immunology

Volumn 178, Issue 2, 2014, Pages 334-341

  Sowmya, S ^a   Sri Manjari, K ^a   Ramaiah, A ^c   Sunitha, T ^a   Nallari, P ^b   Jyothy, A ^a   Venkateshwari, A ^a  

^a OSMANIA UNIVERSITY   (India)

^b OSMANIA UNIVERSITY   (India)

^c Government Maternity Hospital   (India)

Author keywords

Haplotype; Interleukin 10; Pre eclampsia; Reproductive immunology; Th1 Th2

Indexed keywords

INTERLEUKIN 10;

ADULT; ALLELE; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GESTATIONAL AGE; HAPLOTYPE; HUMAN; ODDS RATIO; PREECLAMPSIA; PREGNANCY; PROMOTER REGION; RISK FACTOR; YOUNG ADULT;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GESTATIONAL AGE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; LINKAGE DISEQUILIBRIUM; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS, GENETIC; RISK FACTORS; YOUNG ADULT;

EID: 84908120673     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12402     Document Type: Article

References (46)

1. Salimi S, Farajian-Mashhadi F, Naghavi A etal. Different profile of serum leptin between early onset and late onset preeclampsia. Dis Markers 2014; 2014:1-7.
2. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:592-594.
3. Borzychowski AM, Sargent IL, Redman CWG. Inflammation and preeclampsia. Semin Fetal Neonatal Med 2006; 11:309-316.
4. Roberts JM, Gammill HS. Preeclampsia. Hypertension 2005; 46:1243-1249.
5. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.
6. Mosmann TR, Sad S. The expanding universe of T-cell subsets. Immunol Today 1996; 7:138-146.
7. Liberman AC, Refojo D, Arzt E. Cytokine signaling/transcription factor cross-talk in T cell activation and Th1-Th2 differentiation. Arch Immunol Ther Exp (Warsz) 2003; 51:351-365.
8. Matsuzaki J, Tsuji T, Imazeki I, Ikeda H, Nishimura T. Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases. Autoimmunity 2005; 38:369-375.
9. Kim JM, Brannan CI, Copeland NG. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992; 148:3618-3623.
10. Eskdale J, Kube D, Tesch H. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46:120-128.
11. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun 2000; 1:231-233.
12. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95:9465-9470.
13. Mormann M, Rieth H, Hua TD etal. Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun 2004; 5:246-255.
14. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
15. Marzi M, Vigano D, Trabattoni D etal. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-133.
16. Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod 2000; 15:2011-2017.
17. Wu MY, Chen HF, Chen SU, Chao KH, Yang YS, Ho HN. Increase in production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol 2001; 46:386-392.
18. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol 1999; 163:3491-3495.
19. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19:5444.
20. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999; 7:127-128.
21. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22:1928-1929.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
23. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
24. Howell WM, Rose-Zerilli MJ. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr 2007; 137:194-199.
25. Schneider BG, Camargo MC, Ryckman KK etal. Cytokine polymorphisms and gastric cancer risk: an evolving view. Cancer Biol Ther 2008; 7:157-162.
26. Westendorp RGJ, Langermans JAM, Huizinga TWJ etal. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349:170-173.
27. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of the 5′ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxf) 2003; 42:1295-1298.
28. Yilmaz V, Yentur SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005; 30:188-194.
29. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW. The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 2002; 59:560-569.
30. de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW. Interleukin 10-2849 AA genotype protects against pre-eclampsia. Genes Immun 2004; 5:313-314.
31. Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003; 75:711-717.
32. Stonek F, Hafner E, Metzenbauer M etal. Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin- 10 (IL-10) G1082A polymorphism in women with preeclampsia. J Reprod Immunol 2008; 77:85-90.
33. Sowmya S, Ramaiah A, Sunitha T, Nallari P, Jyothy A, Venkateshwari A. Role of IL-10 -819(t/c) promoter polymorphism in preeclampsia. Inflammation 2014; 37:1022-1027.
34. Zhang X, Hei P, Deng L, Lin J. Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 2007; 13:135-140.
35. Lokossou AG, Dechavanne C, Bouraïma A etal. Association of IL-4 and IL-10 maternal haplotypes with immune responses to P. falciparum in mothers and newborns. BMC Infect Dis 2013; 13:215.
36. Temple SE, Lim E, Cheong KY etal. Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003; 55:629-632.
37. Makris A, Xu B, Yu B, Thornton C, Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 2006; 27:445-451.
38. Wilson JN, Rockett K, Jallow M etal. Analysis of IL-10 haplotypic associations with severe malaria. Genes Immun 2005; 6:462-466.
39. Kamali-Sarvestani E, Kiany S, Gharesi-Fard B, Robati M. Association study of IL-10 and IFNgamma gene polymorphisms in Iranian women with preeclampsia. J Reprod Immunol 2006; 72:118-126.
40. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184:539-548.
41. Ghildyal N, McNeil HP, Gurish MF, Austen KF, Stevens RL. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem 1992; 267:8473-8477.
42. Mertz PM, DeWitt DL, Stetler SW, Wahl LM. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 1994; 269:21322-21329.
43. Roth I, Fisher SJ. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 1999; 205:194-204.
44. Damsky C, Sutherland A, Fisher S. Extracellular matrix 5: adhesive interactions in early mammalian embryogenesis, implantation, and placentation. FASEB J 1993; 7:1320-1329.
45. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype-one cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99:2152-2164.
46. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91:950-960.